App-Quantinova.ai

Effectiveness and Safety of Ticagrelor versus Clopidogrel in Acute Coronary Syndrome A Meta-Analysis of Real - World Data

Sara Al-Balushi - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Quantitative Whole Blood Platelet Aggregation Predicts Occurrence of Subacute Thrombosis in Patients After Percutaneous Coronary or Peripheral Intervention

Nobusada Funabashi - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Adenosine

Lipoprotein(a) Integrates Monocyte-Mediated Thrombosis and Inflammation in Atherosclerotic Cardiovascular Disease

Robert S Rosenson - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Alexander Conant - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Different Distribution of CD163 Positive Macrophages in Thrombus Retrieved From Infarct-Related Artery Atherothrombosis vs. Cardiogenic Thrombosis, Pathological Analyses From the MITO Study

Tomomi Koizumi - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

TMEM16 Antagonists Inhibit Phosphatidylserine-Induced Procoagulant Activity in Endothelial Cells and Protect From Thrombosis in vivo

Alec A Schmaier - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Phosphatidylserine

Using Renal-Specific Cyclo-Oxygenase-2-Deficient Mice to Understand the Pro-Thrombotic Effects of Non-Steroidal Anti-Inflammatory Drugs

Maria Lopes Pires - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Acetylcholine

Outcomes of Patients With Myeloproliferative Neoplasms Admitted for Myocardial Infarction Insights From National Inpatient Sample

Orly Leiva - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Risk of Venous Thromboembolism and Nonrheumatic Valvular Heart Disease in Patients With Elevated Lipoprotein(a) A Retrospective Cohort Study

Evan S Bloch - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Adipokines and Venous Thromboembolism The Multi- Ethnic Study of Atherosclerosis (MESA)

Eric K Broni - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A Rare Case of Patent Foramen Ovale Thrombus Caught in Transit

Rupinder Buttar - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Edoxaban For Pediatric Patients With Cardiac Diseases A Randomized, Open Label, Multicenter Study

Michael A Portman - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Edoxaban

Patent Foramen Ovale With Platypnea-Orthodeoxia Precipitated by Large Hepatic Cyst Requiring Closure Novel Approach

Errol Moras - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Logistic and Machine Learning Approaches to Identify Predictors of Venous Thromboembolism in Covid-19 Patients

Manuela F Sacioto - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Diabetes is Associated With Increased Risk of Major Adverse Cardiovascular Events in Patients Covid-19 A Retrospective U.S. Multicenter Cohort Study

Candrika D Khairani - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Nonspecific Tools Performed Better in Discriminating Major Bleeding From Direct Oral Anticoagulants Than Specific Tools in a Real-World Population With Atrial Fibrillation

Alessandra M Campos-Staffico - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

A Single Center Experience With the Safety and Feasibility of Concomitant Atrial Fibrillation Ablation and Left Atrial Appendage Occlusion Six-Month Outcomes

Ashraf Alzahrani - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

A Rare Case of Refractory Ventricular Arrhythmias Caused by Subacute Aortic Root Thrombosis Following Left Ventricular Assist Device

Rupinder Buttar - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Amiodarone Hydrochloride

Safety of Leadless Pacemakers vs. Transvenous Pacemakers in Patients Older Than 65 Years

Jorge Romero - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Are There Sex Differences in the Imaging Modalities and Early Use of Echocardiography in Elderly Patients With Pulmonary Embolism?

Ghazaleh Mehdipoor - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Filters

7277 Abstracts